Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Team
201-500
employees, estimated range
Backers
1
Ampersand Capital Partners
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
TareBio develops vaccines for cancer and infectious diseases by decoding immune responses to engineer targeted antigens.
ReNewVax logoFounded 2022
Protecting Our Future. ReNewVax is a next-generation bacterial vaccine company developing the first universal vaccine targeting all ca.100…
T cell Based Immunotherapies for Cancer and Chronic Infectious Diseases.
BaseimmuneSeries A $11.3M · 2 yr ago • Founded 2019 • 11-50 employees
404 Err….or The vaccines you're looking for don't exist. Yet….
Explore our innovative broad-spectrum, mutation-agnostic vaccines that are revolutionizing immunization. Discover the enduring, economic…
GIVAX51-200 employees
GIVAX is developing a new class of vaccines to protect children from severe gastroenteritis caused by rotavirus and norovirus. Leveraging…

Overview

Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious diseases.